GRAVITY ( GRVY ) reported preliminary, unaudited consolidated revenue of KRW 113B for Q4, along with consolidated operating profit of KRW 12B. Q4 revenue declined 18.6% quarter over quarter and 12.9% year over year. The company attributed the preliminary results primarily to lower revenues from Ragnarok M: Classic , which remains on track for launch in Korea in the second half of 2026. Unaudited p...
GRAVITY ( GRVY ) reported preliminary, unaudited consolidated revenue of KRW 113B for Q4, along with consolidated operating profit of KRW 12B. Q4 revenue declined 18.6% quarter over quarter and 12.9% year over year. The company attributed the preliminary results primarily to lower revenues from Ragnarok M: Classic , which remains on track for launch in Korea in the second half of 2026. Unaudited preliminary consolidated revenue for 2025 is KRW 560B, and the operating profit is KRW 77B. The balance of cash and cash equivalents and short-term financial instruments was KRW 618,633M as of December 31, 2025. Source: Press Release More on Gravity Seeking Alpha’s Quant Rating on Gravity Financial information for Gravity
In an aerial view, trucks line up to enter a shipping berth at the Port of Oakland on Aug. 26, 2025 in Oakland, California. Justin Sullivan | Getty Images Investors are anxious heading into the final trading session of the week, after AI concerns gripped equity markets again to trigger a fresh sell-off — this time, hitting the logistics and real estate sectors. Read more Dow slides 600 points, S&P...
In an aerial view, trucks line up to enter a shipping berth at the Port of Oakland on Aug. 26, 2025 in Oakland, California. Justin Sullivan | Getty Images Investors are anxious heading into the final trading session of the week, after AI concerns gripped equity markets again to trigger a fresh sell-off — this time, hitting the logistics and real estate sectors. Read more Dow slides 600 points, S&P 500 falls for a third day as AI disruption fears rattle markets Office real estate stocks tumble as AI disruption casualties in the stock market grow by the day Here's how some of the worst-hit stocks were faring in premarket trading on Friday. Trucking and logistics On Thursday, logistics stocks became the latest victims of the AI fear trade, thanks to a new tool from AI firm Algorhythm Holdings . The tool, called SemiCab, touts itself as "the world's most well-orchestrated transportation platform." Logistics giants C.H. Robinson and RXO — which fell as much as 20% each on Thursday — moved in opposite directions ahead of the bell on Friday morning. The former rebounded slightly, adding 0.7%, while RXO extended losses to decline a further 1.5%. Stock Chart Icon Stock chart icon RXO stock price Expeditors International of Washington , which fell more than 16% in Thursday's session, was last seen trading flat in the premarket. After Thursday's 9% loss, J.B. Hunt Transportation Services shed another 0.6% on Friday morning, while XPO was last seen 1% lower. Algorhythm — which surged as much as 30% on Thursday — gained 15% in premarket trading. Stock Chart Icon Stock chart icon Share price Real estate On Thursday, a sell-off of commercial real estate companies entered its second day. CBRE was among the hardest hit, extending its losses into Friday's premarket session with a 0.6% decline. Stock Chart Icon Stock chart icon CBRE share price Jones Lang LaSalle was marginally lower ahead of Friday's opening bell, while Hudson Pacific Properties was flat. The stocks lost almost 8% an...
Sundry Photography Applied Materials ( AMAT ) was in focus on Friday after Wall Street praised the semiconductor equipment maker's guidance . Shares rose 11% in premarket trading, while other chip equipment stocks, such as Lam Research ( LRCX ), ASML ( ASML ), and KLA Corp. ( KLAC ), were mixed. Wells Fargo analyst Joe Quatrochi was impressed with the company's guidance, especially given the risin...
Sundry Photography Applied Materials ( AMAT ) was in focus on Friday after Wall Street praised the semiconductor equipment maker's guidance . Shares rose 11% in premarket trading, while other chip equipment stocks, such as Lam Research ( LRCX ), ASML ( ASML ), and KLA Corp. ( KLAC ), were mixed. Wells Fargo analyst Joe Quatrochi was impressed with the company's guidance, especially given the rising expectations from its peers. “While not providing a C2026 [wafer fab equipment estimate], AMAT expects its semi systems rev to grow >20% y/y—well ahead of prior Street est at +11% y/y,” Quatrochi wrote in a note to clients. “Similar to peers, AMAT expects rev to be 2H-weighted given fab readiness & likely sets up for a strong 2027. AI [remains] a key driver of demand w/ WFE growth led by leading-edge F/L, DRAM / HBM [and advanced] packaging, while we'd positively view updated [expectations] for flat ICAPS & China; we think [this is] supportive of AMAT [wafer fab equipment] outperformance in 2026.” Quatrochi has an Overweight rating and $435 price target on Applied Materials. Evercore ISI analyst Mark Lipacis was also impressed and said he expects shares of Applied Materials to see the valuation gap between it and its peers—ASML, Lam Research, and KLA Corp.—narrow after the report. “We expect this valuation gap to narrow, as WFE accelerates through 2027 and AMAT benefits from acceleration in DRAM + HBM and leading-edge F&L spend,” Lipacis wrote in a note to clients. He has an Outperform rating and a $400 price target on Applied Materials. Bank of America analyst Vivek Arya was even more positive and said it is now the “time to shine” for Applied Materials. “As the largest semicap with the broadest portfolio, AMAT has strong leverage to this multi-year WFE cycle focused in leading-edge F/L and DRAM to support outsized AI demand,” Arya wrote in a note to clients. “Beyond cyclical growth, leadership in DRAM (#1 supplier), advanced packaging, and dep/conductor etch process ste...
watch now VIDEO 8:21 08:21 Treasury Sec. Bessent: Senate should proceed with Warsh hearings for Fed chair despite Powell probe Squawk Box The Senate should move to advance Kevin Warsh , President Donald Trump 's nominee for Federal Reserve chairman, even as a federal criminal investigation into current chair Jerome Powell continues, Treasury Secretary Scott Bessent said Friday. Bessent, in an inte...
watch now VIDEO 8:21 08:21 Treasury Sec. Bessent: Senate should proceed with Warsh hearings for Fed chair despite Powell probe Squawk Box The Senate should move to advance Kevin Warsh , President Donald Trump 's nominee for Federal Reserve chairman, even as a federal criminal investigation into current chair Jerome Powell continues, Treasury Secretary Scott Bessent said Friday. Bessent, in an interview on CNBC's " Squawk Box ," said he believes after speaking this week to Republicans on the Senate Banking Committee that they "are going to proceed" with a nomination hearing. "I think it's important to get the hearings underway, and I think we have an agreement to do that," he said. This is breaking news. Please refresh for updates.
Maddie Meyer/Getty Images News Moderna ( MRNA ) reported better-than-expected Q4 2025 financials on Friday and reaffirmed its 2026 growth target even as the vaccine maker suffered a major regulatory setback for its flu shot candidate last week when the U.S. FDA declined its review. Earlier this week, the Cambridge, Massachusetts-based biotech disclosed that the FDA issued a Refusal-to-File letter ...
Maddie Meyer/Getty Images News Moderna ( MRNA ) reported better-than-expected Q4 2025 financials on Friday and reaffirmed its 2026 growth target even as the vaccine maker suffered a major regulatory setback for its flu shot candidate last week when the U.S. FDA declined its review. Earlier this week, the Cambridge, Massachusetts-based biotech disclosed that the FDA issued a Refusal-to-File letter indicating that the agency will not review its biologics license application for its flu vaccine candidate mRNA-1010. However, the company reiterated plans to record up to 10% of 2026 revenue growth compared to last year, when its topline plunged ~40% YoY to $1.9B, with the majority of sales driven by its COVID-19 vaccine. However, Moderna ( MRNA ) managed to contain its costs as its R&D expenses and SG&A costs fell ~31% YoY and ~13% YoY to roughly $3.1B and $1.0B, respectively, while its net loss dropped ~22% YoY to $2.8B. Reiterating plans to continue cost reduction activities, the company projected approximately $3.0B and $1.0B in R&D and SG&A expenses for 2026, respectively, and estimated $5.5B - $6.0B in year-end cash and investments compared to $5.8B a year ago. During 2025, “we lowered our annual operating expenses by approximately $2.2 billion, significantly surpassing our cost-reduction targets," CEO Stéphane Bancel said. For Q4 2025, the company reported $678M in revenue, beating the consensus by $54.1M, with a ~30% YoY decline, which indicated its lower COVID-19 vaccine sales volumes. Meanwhile, MRNA's GAAP loss per share fell ~28% YoY to $2.11, mainly driven by a 31% YoY decline in R&D expenses, reflecting, among other things, its cost reduction activities and plans to halt large Phase 3 respiratory programs. More on Moderna Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case Moderna: Analyzing The January Rally And The Road Ahead (Rating Upgrade) Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today? Moderna GAAP EPS of -...
Morgan Stanley ’s asset management arm is sounding out investors about shifting a portfolio of India assets from an existing fund into a new vehicle, according to people familiar with the matter. The firm plans to move eight healthcare-focused investments into a so-called continuation vehicle, the people said, asking not to be identified because the conversations are private. It’s seeking to raise...
Morgan Stanley ’s asset management arm is sounding out investors about shifting a portfolio of India assets from an existing fund into a new vehicle, according to people familiar with the matter. The firm plans to move eight healthcare-focused investments into a so-called continuation vehicle, the people said, asking not to be identified because the conversations are private. It’s seeking to raise $500 million for the new India fund strategy and has approached investors on the plan, the people added. The assets include Omega Hospitals and RG Scientific Enterprises Pvt. , one of the people said. Morgan Stanley Investment Management invested in Omega in 2024 with a minority ownership and bought a controlling stake in RG Scientific that same year. A media representative for Morgan Stanley declined to comment. Morgan Stanley Investment Management, a $1.9 trillion manager, invested in the assets through its alternative arm, Morgan Stanley Private Equity Asia. The continuation fundraising comes as more investment firms look for exit routes beyond initial public offerings and mergers. Globally, the secondary market rose 48% to $240 billion in 2025 from a year earlier, according to a report by Jefferies Financial Group Inc.
Meituan warned of its biggest annual loss since at least 2021, underscoring the extent to which a brutal price-based war in food delivery is eroding margins at China’s largest internet companies. The Beijing-based firm expects to record a loss of between 23.3 billion yuan ($3.4 billion) and 24.3 billion yuan for 2025, according to an exchange filing . That’s a stark reversal from a profit of 35.8 ...
Meituan warned of its biggest annual loss since at least 2021, underscoring the extent to which a brutal price-based war in food delivery is eroding margins at China’s largest internet companies. The Beijing-based firm expects to record a loss of between 23.3 billion yuan ($3.4 billion) and 24.3 billion yuan for 2025, according to an exchange filing . That’s a stark reversal from a profit of 35.8 billion yuan in 2024. It booked a loss of more than 23.5 billion yuan in 2021. Citing “unprecedentedly intense” industry competition in 2025, Meituan said it ramped up spending across its ecosystem — from marketing and promotions to incentives for couriers and merchants, while expanding overseas. The investments weighed on profitability for the domestic commerce segment, and the loss-making trend is expected to continue into the first quarter, the company said in the filing. Meituan has been fighting for market share against other Chinese tech giants, including Alibaba Group Holding Ltd. and JD.com Inc. , that are spending billions of yuan on discounts and subsidies to drive deeper into the meal-delivery and quick-commerce market despite weaker consumer demand. Meituan has been forced to respond in kind, depressing margins even as its growth slows. The subsidy-driven price war in China’s online food-delivery market has drawn scrutiny from the country’s top antitrust body, which last month launched an investigation into competition practices in the industry, citing concerns they are distorting the real economy. Read More: China Antitrust Body Probes Intense Competition in Food Delivery In the Friday statement, Meituan said its operations remain stable and that the group has sufficient cash to support the steady development of its businesses, adding that it is “firmly opposed to irrational competition.” The company said it expected to publish finalized annual results by the end of March.
A poll has found differences between men and women’s motivations for watching romance films together, with 20% of men hoping it may result in sex As groups of women block-booking rows of seats with friends to see Wuthering Heights look likely to help propel Emerald Fennell’s adaptation to the top of the Valentine’s weekend box office, a new survey suggests men are amenable to watching romantic mov...
A poll has found differences between men and women’s motivations for watching romance films together, with 20% of men hoping it may result in sex As groups of women block-booking rows of seats with friends to see Wuthering Heights look likely to help propel Emerald Fennell’s adaptation to the top of the Valentine’s weekend box office, a new survey suggests men are amenable to watching romantic movies at home – although their motivations for doing so are mixed. A poll of 2,000 film fans on behalf of the wall-to-wall romance movie Freeview channel Great Romance has found that the top three reasons given by men for watching a romance film are feeling closer to their partner (36%), wanting a quiet life (21%) and thinking it might lead to sex (20%). Twenty per cent said that such films “remind me of the magic of when we met”, while half that number said such an activity was “low effort but still feels like bonding”. Continue reading...
On Feb. 12, Soleus Capital Management, L.P. disclosed a buy of 629,398 shares of Celcuity (NASDAQ:CELC) in a Securities and Exchange Commission (SEC) filing Celcuity is a clinical-stage biotechnology firm focused on innovative cancer diagnostics and targeted therapies, leveraging its CELsignia platform to identify and address specific cellular drivers of cancer. The company’s strategy centers on a...
On Feb. 12, Soleus Capital Management, L.P. disclosed a buy of 629,398 shares of Celcuity (NASDAQ:CELC) in a Securities and Exchange Commission (SEC) filing Celcuity is a clinical-stage biotechnology firm focused on innovative cancer diagnostics and targeted therapies, leveraging its CELsignia platform to identify and address specific cellular drivers of cancer. The company’s strategy centers on advancing Gedatolisib and companion diagnostics to address unmet needs in breast and ovarian cancer treatment. Soleus Capital Management sent a bullish signal to the market with its significant purchase of Celcuity shares. Owning 1.2 million shares on Sept. 30, the firm boosted its position to over 1.8 million shares by the end of the year. Continue reading
NoDerog Keurig Dr Pepper ( KDP ) announced it will expand its board of directors. Effective March 2, independent directors Amie Thuener and William "Bill" Newlands will join the board. Thuener brings 30 years of finance and accounting experience to the beverage company's board and will serve on its Audit & Finance Committee. Having joined Alphabet ( GOOG ) in 2013, she currently holds the position...
NoDerog Keurig Dr Pepper ( KDP ) announced it will expand its board of directors. Effective March 2, independent directors Amie Thuener and William "Bill" Newlands will join the board. Thuener brings 30 years of finance and accounting experience to the beverage company's board and will serve on its Audit & Finance Committee. Having joined Alphabet ( GOOG ) in 2013, she currently holds the position of Vice President, Corporate Controller, and Chief Accounting Officer, with responsibility for global external financial reporting and accounting policy. During her tenure at Alphabet ( GOOG ), Thuener has had responsibility for finance teams for Alphabet's Other Bets, including Verily, Waymo, and others, as well as M&A finance. Newlands brings more than 40 years of experience in the beverage alcohol and consumer packaged goods industries to the board and will serve on its Nominating & Governance Committee. His track record of driving significant business transformation and building leading global brands includes a stint of over seven years as the CEO of Constellation Brands ( STZ ) for just over seven years. Newlands will be stepping down as president and CEO of Constellation Brands ( STZ ) and retiring from the board in April. The board additions were noted to support Keurig Dr Pepper's ( KDP ) transformation and value creation agenda as it approaches the closing of the JDE Peet's acquisition in early Q2 and progresses over the following quarters towards a separation into two independent companies. More on Keurig Dr Pepper Keurig Dr Pepper: On Hold Until The M&A Dust Settles Keurig Dr. Pepper: Acquisition Of JDE Isn't That Bad Beverage blockbuster: Keurig Dr Pepper gets closer to its transformative deal with JDE Peet's Keurig Dr Pepper launches offer for JDE Peet's shares Seeking Alpha’s Quant Rating on Keurig Dr Pepper
The Czech central bank said that core inflation remained elevated in January and continued to represent a reason for monetary policy caution. While headline price growth is likely to stay below target this year, the core measure, which excludes volatile prices, will remain close to its current levels, at least at the start of the year, according to the central bank. “Despite the very favorable dev...
The Czech central bank said that core inflation remained elevated in January and continued to represent a reason for monetary policy caution. While headline price growth is likely to stay below target this year, the core measure, which excludes volatile prices, will remain close to its current levels, at least at the start of the year, according to the central bank. “Despite the very favorable developments in headline inflation, elevated core inflation is a reason for a cautious monetary policy approach,” Petr Sklenar, the central bank’s chief economist, said in a statement Friday. “Persistently high services inflation shows that price developments in the domestic economy have not yet fully normalized.” Core inflation, which shows the underlying demand pressures in the economy, came in at 2.7% last month, slightly undershooting the central bank’s 2.8% forecast. Prices for services rose 4.5% from the previous year, while growth of the closely-watched cost of owner-occupied housing, also called the imputed rent, accelerated to 5.1% year and reached the fastest pace in three years. Read more: Czech Central Bankers Saw Domestic Inflation Risks, Minutes Show Headline price growth slowed to 1.6% mainly due to a decline in energy prices as well as a continued “favorable trend” in food costs, the central bank said.